On May 2, 2019, CISCRP had the privilege of hosting its 2nd Annual User Group Meeting focusing on best practices, lessons learned and ongoing challenges associated with the return of plain language clinical trial results summaries.
The meeting was held at CISCRP’s Liberty Square office in Boston. Attendance in the 2nd Annual User Group Meeting increased over last year’s first meeting. Representatives from a dozen pharmaceutical and biotechnology companies participated in the group discussion including AstraZeneca, Biogen, CSL Behring, EMD Serono, Novartis, Otsuka, UCB, and Vertex Pharmaceuticals.
The User Group Meeting provides an open forum for information sharing and discussion. Meeting participants exchanged ideas and experiences and also provided CISCRP with valuable insights into opportunities to continuously improve on its plain language services.
We want to thank all of the attendees again for their time and participation in the 2nd Annual User Group Meeting. It was a pleasure for CISCRP to host and facilitate this event. CISCRP hopes to continue to see the User Group grow and offer even greater value to participating companies in the coming years.
If you would like to learn more about joining our Plain Language Clinical Trial Summaries User Group, please contact Jay Matthews at [email protected].
Written by Jay Matthews, Business Development Executive